Carcinoma of Unknown Primary Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Condition: Carcinoma of Unknown PrimaryInterventions: Drug: carboplatin; Drug: everolimus; Drug: paclitaxel; Genetic: gene expression analysis; Other: laboratory biomarker analysisSponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)Recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2009 Category: Research Source Type: clinical trials
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Condition: Carcinoma of Unknown PrimaryInterventions: Drug: carboplatin; Drug: everolimus; Drug: paclitaxel; Genetic: gene expression analysis; Other: laboratory biomarker analysisSponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)Recruiting - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2009 Category: Research Source Type: clinical trials
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Condition: Carcinoma of Unknown PrimaryInterventions: Drug: carboplatin; Drug: everolimus; Drug: paclitaxel; Genetic: gene expression analysis; Other: laboratory biomarker analysisSponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)Recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2009 Category: Research Source Type: clinical trials
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Condition: Carcinoma of Unknown PrimaryInterventions: Drug: carboplatin; Drug: everolimus; Drug: paclitaxel; Genetic: gene expression analysis; Other: laboratory biomarker analysisSponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)Recruiting - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2009 Category: Research Source Type: clinical trials
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Condition: Carcinoma of Unknown PrimaryInterventions: Drug: carboplatin; Drug: everolimus; Drug: paclitaxel; Genetic: gene expression analysis; Other: laboratory biomarker analysisSponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)Active, not recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2009 Category: Research Source Type: clinical trials
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Condition: Carcinoma of Unknown PrimaryInterventions: Drug: carboplatin; Drug: everolimus; Drug: paclitaxel; Genetic: gene expression analysis; Other: laboratory biomarker analysisSponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)Recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2009 Category: Research Source Type: clinical trials
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Condition: Carcinoma of Unknown PrimaryInterventions: Drug: carboplatin; Drug: everolimus; Drug: paclitaxel; Genetic: gene expression analysis; Other: laboratory biomarker analysisSponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)Recruiting - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2009 Category: Research Source Type: clinical trials
